| Clipos™ Control of Anionic Clodronate Encapsulated Liposomes, DiA Labeled |
CDL7001FA-A |
PC/PG/Cholesterol |
|
INQUIRY
|
| Clipos™ Control of Anionic Clodronate Encapsulated Liposomes, Dil Labeled |
CDL7001F-A |
PC/PG/Cholesterol |
|
INQUIRY
|
| Clipos™ Control of Anionic Clodronate Encapsulated Liposomes, DiO Labeled |
CDL7001FO-A |
PC/PG/Cholesterol |
|
INQUIRY
|
| Clipos™ Control of Anionic Clodronate Encapsulated Liposomes, DiR Labeled |
CDL7001FR-A |
PC/PG/Cholesterol |
|
INQUIRY
|
| Clipos™ Control of Clodronate Encapsulated Liposomes, DiA Labeled |
CDECLD-1685 |
L-α-Phosphatidylcholine (PC)/Cholesterol (70/30 molar ratio) |
100 nm |
INQUIRY
|
| Clipos™ Control of Clodronate Encapsulated Liposomes, DiD Labeled |
CDECLD-1691 |
L-α-Phosphatidylcholine (PC)/Cholesterol (70/30 molar ratio) |
100 nm |
INQUIRY
|
| Clipos™ Control of Clodronate Encapsulated Liposomes, DiI Labeled |
CDECLD-1688 |
L-α-Phosphatidylcholine (PC)/Cholesterol (70/30 molar ratio) |
100 nm |
INQUIRY
|
| Clipos™ Control of Clodronate Encapsulated Liposomes, DiO Labeled |
CDECLD-1689 |
L-α-Phosphatidylcholine (PC)/Cholesterol (70/30 molar ratio) |
100 nm |
INQUIRY
|
| Clipos™ Control of Clodronate Encapsulated Liposomes, DiR Labeled |
CDECLD-1687 |
L-α-Phosphatidylcholine (PC)/Cholesterol (70/30 molar ratio) |
100 nm |
INQUIRY
|
| Clipos™ Control of Neutral Clodronate Encapsulated Liposomes, DiA Labeled |
CDL7001FA-N |
PC/Cholesterol |
|
INQUIRY
|
| Clipos™ Control of Neutral Clodronate Encapsulated Liposomes, DiD Labeled |
CDL7001FD-N |
PC/Cholesterol |
|
INQUIRY
|
| Clipos™ Control of Neutral Clodronate Encapsulated Liposomes, Dil Labeled |
CDL7001F-N |
PC/Cholesterol |
|
INQUIRY
|
| Clipos™ Control of Neutral Clodronate Encapsulated Liposomes, DiO Labeled |
CDL7001FO-N |
PC/Cholesterol |
|
INQUIRY
|
| Clipos™ Control of Neutral Clodronate Encapsulated Liposomes, DiR Labeled |
CDL7001FR-N |
PC/Cholesterol |
|
INQUIRY
|
| Clipos™ NBD labeled ATP Encapsulated DOTAP Liposomes, PEGylated, Lyophilized |
CDEFADG-1153 |
DOTAP/Cholesterol/PEG2000/NBD-lipid (65/29/5/1 molar ratio) |
100 nm (after hydration) |
INQUIRY
|
| Clipos™ NBD labeled ATP Encapsulated DOTAP Liposomes, PEGylated, Lyophilized |
CDEFADG-1162 |
DOTAP/DOPC/Cholesterol/PEG2000/NBD-lipid (1/64/29/5/1 molar ratio) |
100 nm (after hydration) |
INQUIRY
|
| Clipos™ NBD labeled ATP Encapsulated DOTAP Liposomes, PEGylated, Lyophilized |
CDEFADG-1159 |
DOTAP/DOPC/Cholesterol/PEG2000/NBD-lipid (10/55/29/5/1 molar ratio) |
100 nm (after hydration) |
INQUIRY
|
| Clipos™ NBD labeled ATP Encapsulated DOTAP Liposomes, PEGylated, Lyophilized |
CDEFADG-1161 |
DOTAP/DOPC/Cholesterol/PEG2000/NBD-lipid (2.5/62.5/29/5/1 molar ratio) |
100 nm (after hydration) |
INQUIRY
|
| Clipos™ NBD labeled ATP Encapsulated DOTAP Liposomes, PEGylated, Lyophilized |
CDEFADG-1158 |
DOTAP/DOPC/Cholesterol/PEG2000/NBD-lipid (20/45/29/5/1 molar ratio) |
100 nm (after hydration) |
INQUIRY
|
| Clipos™ NBD labeled ATP Encapsulated DOTAP Liposomes, PEGylated, Lyophilized |
CDEFADG-1157 |
DOTAP/DOPC/Cholesterol/PEG2000/NBD-lipid (30/35/29/5/1 molar ratio) |
100 nm (after hydration) |
INQUIRY
|
